Skip to main content
Fig. 1 | BMC Musculoskeletal Disorders

Fig. 1

From: Effects of secukinumab on bone mineral density and bone turnover biomarkers in patients with ankylosing spondylitis: 2-year data from a phase 3 study, MEASURE 1

Fig. 1

Normal BMD, Osteopenia, and Osteoporosis Rates in Postmenopausal Women and Men ≥50 years of age through Week 104. Data presented as observed. Normal BMD, T-score ≥ − 1.0; Osteopenia, − 1.0 > T-score > − 2.5; and Osteoporosis, T-score ≤ − 2.5. N, total number of patients; n, number of evaluable patients

Back to article page

BMC Musculoskeletal Disorders

ISSN: 1471-2474

Contact us